WallStreetZenWallStreetZen

NASDAQ: PROK
Prokidney Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their PROK stock forecasts and price targets.

Forecast return on equity

Is PROK forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is PROK forecast to generate an efficient return on assets?

Company
-3.98%
Industry
35.65%
PROK is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PROK earnings per share forecast

What is PROK's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.32
Avg 2 year Forecast
-$0.50
Avg 3 year Forecast
-$0.65

PROK revenue growth forecast

How is PROK forecast to perform vs Biotechnology companies and vs the US market?

Company
2,205.99%
Industry
64.17%
Market
10.07%
PROK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PROK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PROK vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PROK$0.89N/AN/A
TSVT$4.99$5.00+0.20%Hold
CMPX$1.86$15.67+742.31%Strong Buy
SLDB$3.31$15.67+373.32%Strong Buy
VNDA$4.51$20.00+343.46%Buy
View Top Biotech Stocks

Prokidney Stock Forecast FAQ

What is PROK's earnings growth forecast for 2025-2027?

(NASDAQ: PROK) Prokidney's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.96%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.59%.

Prokidney's earnings in 2025 is -$61,186,000.On average, 4 Wall Street analysts forecast PROK's earnings for 2025 to be -$94,394,992, with the lowest PROK earnings forecast at -$160,983,707, and the highest PROK earnings forecast at $93,663,248. On average, 3 Wall Street analysts forecast PROK's earnings for 2026 to be -$145,382,922, with the lowest PROK earnings forecast at -$163,910,683, and the highest PROK earnings forecast at -$134,640,919.

In 2027, PROK is forecast to generate -$188,789,984 in earnings, with the lowest earnings forecast at -$240,012,072 and the highest earnings forecast at -$137,567,895.

If you're new to stock investing, here's how to buy Prokidney stock.

What is PROK's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: PROK) forecast ROE is N/A, which is considered weak.

What is PROK's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: PROK) Prokidney's current Earnings Per Share (EPS) is -$0.62. On average, analysts forecast that PROK's EPS will be -$0.32 for 2025, with the lowest EPS forecast at -$0.55, and the highest EPS forecast at $0.32. On average, analysts forecast that PROK's EPS will be -$0.50 for 2026, with the lowest EPS forecast at -$0.56, and the highest EPS forecast at -$0.46. In 2027, PROK's EPS is forecast to hit -$0.65 (min: -$0.82, max: -$0.47).

What is PROK's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: PROK) forecast ROA is -3.98%, which is lower than the forecast US Biotechnology industry average of 35.65%.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.